Provided by Healio
May 22, 2013
ORLANDO, Fla. — Andrew Muir, MD, clinical director, hepatology at Duke University Medical Center, offers an update on the most current hepatitis C research that was presented at Digestive Disease Week 2013.
With many new drugs coming forward, Muir said he provides his patients with time frames on the availability of these medications, including the much-anticipated interferon-free regimens. By understanding the regimens, a patient’s liver disease and what’s right for them, he says individualizing plans allows clinicians to better guide patients on timelines and expectations.
No comments:
Post a Comment